Company / PP&E (Net)
Valion Bio, Inc. PP&E (Net) History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$119.0K
FY2024
5-year range
$12.0K / $122.0K
FY2022-FY2024
Trend
-2.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $12,000 to $119,000 over the past 2 years.
Based on SEC 10-K filings.
$119,000 in FY2024.
Improved from $12,000 to $119,000 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, pp&e (net) decreased 2.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $119.0K | -2.5% |
| FY2023 | $122.0K | +916.7% |
| FY2022 | $12.0K | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026